{"title":"A Basket Trial Design Based on Power Priors","authors":"Lukas Baumann, Lukas D. Sauer, Meinhard Kieser","doi":"10.1080/19466315.2024.2402275","DOIUrl":"https://doi.org/10.1080/19466315.2024.2402275","url":null,"abstract":"In basket trials a treatment is investigated in several subgroups. They are primarily used in oncology in early clinical phases as single-arm trials with a binary endpoint. For their analysis prima...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"31 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gene Pennello, Freda Cooner, Telba Irony, Karen Bandeen-Roche, Shanti Gomatam, Thomas Gwise, Larry Kessler, Richard Kotz, Thomas Louis, Kristen Meier, Norberto Pantoja-Galicia, Nicholas Petrick, Estelle Russek-Cohen, Laura Thompson, Jingjing Ye, Lilly Yue
{"title":"Remembering Gregory Campbell (1949-2023): An Accomplished Leader, Mentor, and Biostatistical Innovator","authors":"Gene Pennello, Freda Cooner, Telba Irony, Karen Bandeen-Roche, Shanti Gomatam, Thomas Gwise, Larry Kessler, Richard Kotz, Thomas Louis, Kristen Meier, Norberto Pantoja-Galicia, Nicholas Petrick, Estelle Russek-Cohen, Laura Thompson, Jingjing Ye, Lilly Yue","doi":"10.1080/19466315.2024.2395196","DOIUrl":"https://doi.org/10.1080/19466315.2024.2395196","url":null,"abstract":"Published in Statistics in Biopharmaceutical Research (Just accepted, 2024)","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"271 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142214769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaofei Liu, Norbert Benda, Clemens Mittmann, Armin Koch
{"title":"Combining Recurrent and Terminal Events Into a Composite Endpoint May Be Problematic","authors":"Xiaofei Liu, Norbert Benda, Clemens Mittmann, Armin Koch","doi":"10.1080/19466315.2024.2395404","DOIUrl":"https://doi.org/10.1080/19466315.2024.2395404","url":null,"abstract":"In clinical trials for chronic heart failure (CHF), time to a composite of first hospitalization for worsening heart failure or death is a widely accepted primary efficacy measure. Motivated by low...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"18 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142214768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Simultaneous Confidence Intervals for Signal Detection and Ascertaining Precision of Adverse Event Rates in Clinical Trials","authors":"Guoqing Diao, Margaret Gamalo, Ram Tiwari","doi":"10.1080/19466315.2024.2388523","DOIUrl":"https://doi.org/10.1080/19466315.2024.2388523","url":null,"abstract":"The marketing authorization of a medicinal product is contingent upon demonstration of safety and efficacy in support of the product’s labeled conditions of use. To demonstrate safety, one group of...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"15 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141941182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Duy Ngo, Daniel Quartey, Patrick M Schnell, Richard Baumgartner, Shahrul Mt-Isa, Dai Feng
{"title":"Bayesian shrinkage estimation of credible subgroups for count data with excess zeros","authors":"Duy Ngo, Daniel Quartey, Patrick M Schnell, Richard Baumgartner, Shahrul Mt-Isa, Dai Feng","doi":"10.1080/19466315.2024.2388520","DOIUrl":"https://doi.org/10.1080/19466315.2024.2388520","url":null,"abstract":"Heterogeneity of treatment effects due to heterogeneous patient characteristics often arises in clinical trials. Subgroup analysis and the analysis of interactions are the most common approaches fo...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"3 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141941313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Statistics Post-Pandemic: Paving the Scientific Path to Treatments, Vaccines, and Diagnostics—Special Issue for the 2022 Regulatory-Industry Statistics Workshop","authors":"Chia-Wen Ko, Hope B. Knuckles","doi":"10.1080/19466315.2024.2368367","DOIUrl":"https://doi.org/10.1080/19466315.2024.2368367","url":null,"abstract":"Published in Statistics in Biopharmaceutical Research (Vol. 16, No. 3, 2024)","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"23 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141941183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"MT-Keyboard: A Bayesian Model-assisted Interval Design to Account for Toxicity Grades and Types for Phase I Trials","authors":"Kai Chen, Li Wang, Ying Yuan","doi":"10.1080/19466315.2024.2368802","DOIUrl":"https://doi.org/10.1080/19466315.2024.2368802","url":null,"abstract":"Conventionally, dose finding trials are based on dose-limiting toxicity (DLT) that only captures the most severe toxicities, e.g., treatment related grade 3 or higher toxicity according to the NCI ...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"15 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141516509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marian Mitroiu, Steven Teerenstra, Katrien Oude Rengerink, Frank Pétavy, Kit CB Roes
{"title":"Possible data-generating models of longitudinal continuous outcomes and intercurrent events to investigate estimands","authors":"Marian Mitroiu, Steven Teerenstra, Katrien Oude Rengerink, Frank Pétavy, Kit CB Roes","doi":"10.1080/19466315.2024.2369266","DOIUrl":"https://doi.org/10.1080/19466315.2024.2369266","url":null,"abstract":"We aimed to explore data-generating models to jointly simulate outcomes and intercurrent events for randomised clinical trials to enable the investigation of estimands.We developed four possible da...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"96 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141507320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A statistical method for protocol modifications with heterogeneous population variances","authors":"Chieh Chiang, Yuh-Jenn Wu, Li-Hsueh Cheng, Ching-Ti Liu, Chin-Fu Hsiao","doi":"10.1080/19466315.2024.2369267","DOIUrl":"https://doi.org/10.1080/19466315.2024.2369267","url":null,"abstract":"During the course of a clinical trial, the procedure may need to be modified based on medical or practical results. For example, in trials with low recruitment rates, the data monitoring committee ...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"145 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141613835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination Trials","authors":"Mengyi Lu, Jingyi Zhang, Ying Yuan, Ruitao Lin","doi":"10.1080/19466315.2024.2370403","DOIUrl":"https://doi.org/10.1080/19466315.2024.2370403","url":null,"abstract":"Drug combinations are increasingly utilized in cancer treatment to enhance drug effectiveness through synergistic therapeutic effects. However, determining the optimal biological dose combination (...","PeriodicalId":51280,"journal":{"name":"Statistics in Biopharmaceutical Research","volume":"74 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141615027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}